MEDTRONIC IRELAND ENDURANT II ILIAC STENT GRAFT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TR
|
Back to Search Results |
|
Model Number ETLW1616C124EE |
Device Problems
Device Markings/Labelling Problem (2911); Positioning Problem (3009)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 09/17/2023 |
Event Type
malfunction
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
An endurant limb (etlw1616c124ee) was intended to be implanted during the endovascular treatment of a 80mm abdominal aortic aneurysm.It was reported during the index procedure the main body stent graft was successfully implanted in the patient.An new unopened endurant limb stent (etlw1616c124ee ) was prepped for delivery into the patients iliac artery. the hydrophilic coating was activated and the guide wire delivery system was used however it was found that it could not be inserted.Despite repeated attempts by the physician the delivery system could not enter the blood vessel.It was then identified that the model of the endurant limb stent graft was (etlw1624c124ee) whereas the outer packaging model of the stent indicated it should have been etlw1616c124ee.The two model numbers were inconsistent.Due to the inconsistency between the two models numbers the device was replaced with a newendurant limb (etlw1616c124ee) and the procedure was successfully completed.Per the physician the cause was attributed to a device marking issue, the inconsistency between the outer packaging model and the actual stent model within the package.No additional clinical sequelae were provided, and the patient is fine.
|
|
Manufacturer Narrative
|
Product analysis :two (2) images were received from the account.The first image of the shelf carton label identified the product as etlw1616c124ee; serial # (b)(6); endurant ii limb stent graft device.The second image of the device handle label identified the device as a 16x24x124 endurant ii bifurcate stent graft device.The reported device marking issue was confirmed based on the images received.B5; additional information received: it was confirmed during the procedure, the box was opened away from any other endurant limbs.It was said no other 124 limb could have been mixed up with the affected device when the box was opened.The seal was intact when the pouch of the etlw1616c124ee, serial no:(b)(6); was opened.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|